Sun Pharma launches Suncros in OTC segment, eyes 30% market share – Feedback

Drug major Sun Pharmaceutical Industries today launched its sunscreen brand ‘Suncros’ through its Global Consumer Healthcare business vertical with a target of garnering 30 per cent market share in the next 2-3 years.

Suncros was available only in the prescription segment till now. “Suncros has an 18 per cent market share and we are looking at a 30 per cent market share in two to three years,” Sun Pharma India Business Chief Executive Officer Abhay Gandhi told reporters here. The total sunscreen market in India is estimated to be worth Rs 380 crore, growing at 25 per cent, of which one-third is the prescription segment. Sun Pharma entered the consumer healthcare business with the acquisition of Ranbaxy, which launched Suncros in 2005.

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *